Sustained low-dose treatment with the Histone deacetylase inhibitor LBH589 induces terminal differentiation of osteosarcoma cells

by Cain, J.E, McCaw, A, Jayasekara, W.S.N, Rossello, F.J, Marini, K.D, Irving, A.T, Kansara, M, Thomas, D.M, Ashley, D.M, Watkins, D.N
Published 2020